Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer

被引:92
|
作者
Rollin, Jerome
Regina, Sandra
Vourc'h, Patrick
Iochmann, Sophie
Blechet, Claire
Reverdiau, Pascale
Gruel, Yves
机构
[1] Fac Med Tours, INSERM, U618, F-37032 Tours, France
[2] IFR 135, F-37000 Tours, France
[3] INSERM, U619, F-37000 Tours, France
关键词
MMP-2; MMP-9; TFPI-2; non-small cell lung cancer; polymorphism; gene expression; prognosis;
D O I
10.1016/j.lungcan.2006.11.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinases (MMP) including MMP-2 and MMP-9 play a major role in tumour invasion by proteolysing the extracellular matrix. Their activation, particularly that of MMP-9, is partly dependent on plasmin that is inhibited by TFPI-2 (tissue factor pathway inhibitor-2), a serine protease inhibitor whose gene expression is decreased in about one-third of non-small cell lung cancers (NSCLC). In addition, MMP-2 and MMP-9 are essential in the development of NSCLC and can be regulated by functional promoter polymorphisms. In this study, the -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 polymorphisms were analysed in 90 NSCLC patients and 90 controls. In addition, the promoter region of the TFPI-2 gene was screened for sequence variations in both groups by DHPLC. A -167G/A polymorphism was identified in 3% of controls whereas none of the 90 patients exhibited this genetic variation in the TFPI-2 promoter region. Moreover, no difference in -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 genotypes was found between cases and controls. However, the homozygous -1562CC MMP-9 genotype was more frequent in patients with squamous cell carcinoma than in controls (p=0.018). When genotype distributions were compared to MMP-2 and MMP-9 gene expression in tumours, no relationship was found with the -1306 MMP-2 and -1562 MMP-9 polymorphisms. In contrast, tumour MMP-2 gene expression was tower in homozygous -735CC patients than in those with CT or TT genotypes. In addition, the survival time was longer in patients with the MMP-2 -735T allele than in those with the CC genotype (p = 0.02). The relative risk of death was increased 2.6-fold in -735CC patients (p = 0.045; 95% CI = 1.0-6.7). The results of this study suggest that the -735C/T MMP-2 polymorphism might be an independent prognostic marker in NSCLC, but this should be confirmed in a larger cohort of patients. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [41] The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms
    Pannu, Hariyadarshi
    Kim, Dong H.
    Guo, Dongchuan
    King, Terri M.
    Van Ginhoven, Grace
    Chin, Toinette
    Chang, Katherine
    Qi, Yuhua
    Shete, Sanjay
    Milewicz, Dianna M.
    JOURNAL OF NEUROSURGERY, 2006, 105 (03) : 418 - 423
  • [42] Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma
    Gozdzialska, Anna
    Wojas-Pelc, Anna
    Drag, Jagoda
    Brzewski, Pawel
    Jaskiewicz, Jerzy
    Pastuszczak, Maciej
    MOLECULAR BIOLOGY REPORTS, 2016, 43 (10) : 1027 - 1033
  • [43] The Association of MMP-2, MMP-9, and MMP-13 Gene Polymorphisms With Knee Osteoarthritis in the Greek Population
    Milaras, Christos
    Lepetsos, Panagiotis
    Pampanos, Andreas
    Kenanidis, Eustathios
    Macheras, George A.
    Mavrogianni, Despoina
    Dafou, Dimitra
    Potoupnis, Michael
    Tsiridis, Eleftherios
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [44] Expression of KiSS-1 and MMP-9 in Non-Small Cell Lung Cancer and Their Relations to Metastasis and Prognosis
    Hodges, K. B.
    Zheng, S.
    Chang, Y.
    Sun, Y.
    Ma, X.
    Yi, X.
    Cheng, L.
    MODERN PATHOLOGY, 2010, 23 : 403A - 403A
  • [45] Expression of KiSS-1 and MMP-9 in Non-Small Cell Lung Cancer and Their Relations to Metastasis and Prognosis
    Hodges, K. B.
    Zheng, S.
    Chang, Y.
    Sun, Y.
    Ma, X.
    Yi, X.
    Cheng, L.
    LABORATORY INVESTIGATION, 2010, 90 : 403A - 403A
  • [46] Protein Expression and Significance of VEGF, EGFR and MMP-9 in Non-Small Cell Lung Carcinomas
    Jin, Yi
    Li, Jia-Ping
    Tang, Lu-ying
    Chen, Jian-ning
    Feng, Zhi-ying
    Liu, Yong
    Zhou, Jing
    Shao, Chun-kui
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (06) : 1473 - 1476
  • [47] Expression of MMP-2 and MMP-9 in patients with multiple myeloma
    Skliris, A.
    Labropoulou, V.
    Carina, S.
    Magne, B.
    Karamanos, N.
    Papageorgakopoulou, N.
    Theocharis, A.
    FEBS JOURNAL, 2008, 275 : 240 - 240
  • [48] Expression of metalloproteinases MMP-2 and MMP-9 in antrochoanal polyps
    Topal, Ozgul
    Erbek, Selim S.
    Kiyici, Halil
    Cakmak, Ozcan
    AMERICAN JOURNAL OF RHINOLOGY, 2008, 22 (04): : 339 - 342
  • [49] Expression of KISS1 and MMP-9 in Non-small Cell Lung Cancer and Their Relations to Metastasis and Survival
    Zheng, Suqin
    Chang, Yanhe
    Hodges, Kurt B.
    Sun, Ying
    Ma, Xiaobing
    Xueyi
    Williamson, Sean R.
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Cheng, Liang
    ANTICANCER RESEARCH, 2010, 30 (03) : 713 - 718
  • [50] PKCζ, MMP-2 and MMP-9 expression in lung adenocarcinoma and association with a metastatic phenotype
    Cai, Xiaoshan
    Zhu, Hongguang
    Li, Ying
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 8301 - 8306